STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($) |
6 Months Ended | |||
|---|---|---|---|---|
Sep. 29, 2025 |
Jun. 27, 2026 |
Jun. 28, 2025 |
Dec. 27, 2025 |
|
| Subsidiary, Sale of Stock [Line Items] | ||||
| Common stock, par value | $ 0.01 | $ 0.01 | ||
| Unrecognized compensation expense | $ 9,900,000 | |||
| Weighted average period | 2 years 3 months | |||
| Option granted | 724,638 | |||
| Stock-based compensation | $ 1,468,849 | $ 1,522,109 | ||
| Equity Option [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Unrecognized compensation expense | $ 1,700,000 | |||
| Weighted average period | 3 years 3 months 18 days | |||
| Chief Executive Officer [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Option granted | 724,638 | |||
| Strike price | $ 3.21 | |||
| Vesting period | 4 years | |||
| Stock-based compensation | $ 300,000 | |||
| Securities Purchase Agreement [Member] | Private Investment in Public Equity Financing [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Number of shares issued | 19,545,950 | |||
| Common stock, par value | $ 0.01 | |||
| Net proceeds from the offering | $ 38,100,000 | |||
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|